CODX logo

CODX
Co-Diagnostics Inc

31,650
Loading...
Loading...
News
all
press releases
Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing
Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing PR Newswire SALT...
PR Newswire·17h ago
News Placeholder
More News
News Placeholder
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit PR Newswire SALT LAKE CITY, Oct. 13, 2025 SALT LAKE CITY, Oct. 13, 2025 /PRNewswire...
PR Newswire·4d ago
News Placeholder
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates
CoDiagnostics (CODX) delivered earnings and revenue surprises of +8.00% and -45.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates
IceCure Medical (ICCM) delivered earnings and revenue surprises of +200.00% and -34.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
Progyny (PGNY) delivered earnings and revenue surprises of +9.09% and +3.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
Charles River (CRL) delivered earnings and revenue surprises of +24.80% and +5.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.
Zacks·3mo ago
News Placeholder
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Zacks·5mo ago
News Placeholder
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates
chainwire·5mo ago
News Placeholder
Concentra Group (CON) Tops Q1 Earnings and Revenue Estimates
chainwire·5mo ago

Latest CODX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.